Of note, therapeutic DBS led to modulation of the dopaminergic system in the DAT-tg rats, which correlates with the mechanism of DBS in TS patients (see SI, Figs. S2–S3 and Table S3)77. This evidence concerns the gene SLC6A3 and Timothy syndrome.